Investors

Press Releases

Nov 18, 2024
Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results
Keep Reading
Nov 14, 2024
Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference
Keep Reading
Nov 07, 2024
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Keep Reading
Oct 31, 2024
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
Keep Reading
Oct 30, 2024
Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics
Keep Reading
Oct 24, 2024
Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024
Keep Reading
Oct 22, 2024
Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash
Keep Reading
Oct 15, 2024
Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer
Keep Reading
Sep 12, 2024
Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
Keep Reading
Sep 09, 2024
Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels
Keep Reading